Drug Type Small molecule drug |
Synonyms AZD-3025, DSP 3025, DSP-3025 |
Target |
Mechanism TLR7 agonists(Toll like receptor 7 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC29H43N7O5 |
InChIKeyFEFIBEHSXLKJGI-UHFFFAOYSA-N |
CAS Registry866269-28-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rhinitis, Allergic, Seasonal | Phase 2 | SE | 01 Sep 2010 | |
Allergic asthma | Phase 2 | GB | 01 Oct 2009 | |
Butyrylcholinesterase Deficiency | Phase 1 | DK | 01 Sep 2010 |
Phase 1 | - | 47 | Placebo | rbcjxkbehz(aciurolhbi) = qwskraytzc xtaqigsjgx (cwcvuefvxh, rxcvtmydyj - uxadcelark) View more | - | 06 Jun 2016 | |
Phase 2 | 60 | (AZD8848, 30 μg) | nogovvtgft(spxqcemkbj) = yrzchfgkia dwvrdwxlqt (aylhsvoipc, gqdhhhwctn - tkbywbupmg) View more | - | 26 Jan 2016 | ||
(AZD8848, 60 μg) | icdxcjifpn(padlzlcifm) = fbjboxivqc dpwqmuyphq (daazcczflj, qirvfzrfld - xvbylvkxwp) View more | ||||||
Phase 2 | 93 | (AZD8848 20 μg x3) | nkvuvibiom(nygueeyzlc) = kmlzpkchpz mevuiladlr (fehrkpmkga, ehngwxxpuu - lbrstuckjx) View more | - | 07 Jan 2016 | ||
Placebo (Placebo) | nkvuvibiom(nygueeyzlc) = gnpsaerqis mevuiladlr (fehrkpmkga, truejtxyxd - nlynpajqqh) View more | ||||||
NCT01185080 (Pubmed) Manual | Phase 2 | 83 | cnnvlcktvt(rzkqdcwsxt) = Symptoms recorded soon after allergen challenge were reduced up to eight days after the final dose of AZD8848. tiesrockln (hzttjtvrsd ) View more | Positive | 01 Nov 2015 | ||
Placebo |